The decision by the US Food and Drug Administration (FDA) on whether millions of Covid-19 vaccines manufactured by Johnson & Johnson (J&J) can be released has been delayed and is likely to come later in the week, the head of SA’s medicines regulator said on Monday.

The FDA is in the process of determining whether substandard manufacturing conditions at troubled J&J contractor Emergent BioSolutions have been fixed. It is also looking into the extent to which the contamination issues it identified earlier this year affect batches of vaccines manufactured by J&J contractors that relied on ingredients supplied by Emergent, including Aspen Pharmacare...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now